Free equity investment tool of Japanese companies

Financial Statement Details

Annual

First quarter

Second quarter

Third quarter

Sponsored Link

Related Company

Kuraray

Aica Kogyo

ONO PHARMACEUTICAL

Kao

エスケー化研

TSUMURA & CO.

ROHTO PHARMACEUTICAL

KUMIAI CHEMICAL INDUSTRY

NIPPON KAYAKU

Hitachi Chemical

長谷川香料

ADEKA

Toray Industries

Nichi-Iko Pharmaceutical

Takeda Pharmaceutical

EDIUNET Related Ranking

EDIUNET

EDIUNET Credit Rating

EDIUNET Industry Avg

EDIUNET Prefectures

Yuho! Industry

EDIUNET Rating News

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

1/28 Retail Trade (CAWACHI:A etc...

1/27 Banks (The Awa Bank:BBB→A)

1/23 Chemicals (Milbon:AA→AAA)

1/21 Glass & Ceramics Products (..

1/21 Machinery (TSUDAKOMA:C)

1/21 Other Services (Netindex.:CC)

1/20 Other Products (Kurogane Kos..

1/20 Wholesale Trade (リーバイ・..

1/20 Other Services (川崎地質:BB→..

1/17 Chemicals (Kawaguchi Chemica..

 RSS

 Company RSS

 Daily RSS

Sponsored Link

Recently Download Chart

Nissan Motor

PIONEER etc.

NITCHITSU　

日本セラミック

日本セラミック

Financial Statement Details: ADEKA (Annual )

Two or more periods are displayed by each of subject collectively.Two or more companies can be compared and financial statement data can also be downloaded.

【Analysis Menu】 Outline Statement Rating Indicator Download

Sponsored Link

*Free Download Financial Statement data

F/S Outline: ADEKA (Annual )

Switch ViewU-ChartU-Chart and F/SF/S

Consolidated :Balance sheet (B/S) Consolidated | Non-Consolidated | Small | Large
U-Chart(pie chart)	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Cash etc. Other Current Assets Tangible Assets Intangible Assets Investment etc. Current Liabilities Fixed Liabilities Capital stock Capital surplus etc.	*IN(*Right half), OUT(*Left half), BALANCE(*Net Assets)
	[BS] 2009-03-31  *  Total: ¥ 192 B  *  Net: ¥ 116 B  (Ratio: 60.44%)	[BS] 2010-03-31  *  Total: ¥ 203 B  *  Net: ¥ 123 B  (Ratio: 60.61%)	[BS] 2011-03-31  *  Total: ¥ 207 B  *  Net: ¥ 126 B  (Ratio: 61.02%)	[BS] 2012-03-31  *  Total: ¥ 210 B  *  Net: ¥ 128 B  (Ratio: 61.02%)	[BS] 2013-03-31  *  Total: ¥ 222 B  *  Net: ¥ 137 B  (Ratio: 61.65%)
Financial Statement Details	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Cash etc.	¥ 19 B	¥ 24 B	¥ 25 B	¥ 24 B	¥ 28 B
Other Current Assets	¥ 69 B	¥ 74 B	¥ 81 B	¥ 85 B	¥ 87 B
Tangible Assets	¥ 71 B	¥ 69 B	¥ 68 B	¥ 68 B	¥ 71 B
Intangible Assets	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B
Investment etc.	¥ 28 B	¥ 30 B	¥ 29 B	¥ 28 B	¥ 30 B
Total Assets	¥ 192 B	¥ 203 B	¥ 207 B	¥ 210 B	¥ 222 B
Current Liabilities	¥ 52 B	¥ 52 B	¥ 53 B	¥ 60 B	¥ 55 B
Fixed Liabilities	¥ 23 B	¥ 27 B	¥ 27 B	¥ 21 B	¥ 30 B
Capital stock	¥ 22 B	¥ 22 B	¥ 22 B	¥ 22 B	¥ 22 B
Capital surplus etc.	¥ 93 B	¥ 100 B	¥ 103 B	¥ 105 B	¥ 114 B
Liabilities and net assets	¥ 192 B	¥ 203 B	¥ 207 B	¥ 210 B	¥ 222 B
Consolidated :Income statement (P/L) Consolidated | Non-Consolidated | Small | Large
U-Chart(pie chart)	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Sales Cost of Sales Other income SG&A Other expenses Net income	*IN(*Right half), OUT(*Left half), BALANCE(*Net Income)
	[PL] 2009-03-31  *  Sales: ¥ 176 B  *  Income: ¥ 1 B  (Ratio: 0.69%)	[PL] 2010-03-31  *  Sales: ¥ 159 B  *  Income: ¥ 6 B  (Ratio: 4.24%)	[PL] 2011-03-31  *  Sales: ¥ 178 B  *  Income: ¥ 6 B  (Ratio: 3.88%)	[PL] 2012-03-31  *  Sales: ¥ 170 B  *  Income: ¥ 3 B  (Ratio: 2.22%)	[PL] 2013-03-31  *  Sales: ¥ 184 B  *  Income: ¥ 7 B  (Ratio: 4.12%)
Financial Statement Details	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Sales	¥ 176 B	¥ 159 B	¥ 178 B	¥ 170 B	¥ 184 B
Cost of Sales	¥ 143 B	¥ 123 B	¥ 135 B	¥ 134 B	¥ 146 B
Gross profit	¥ 32 B	¥ 36 B	¥ 42 B	¥ 35 B	¥ 38 B
Other income	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 2 B
SG&A	¥ 25 B	¥ 25 B	¥ 27 B	¥ 27 B	¥ 28 B
Other expenses	¥ 6 B	¥ 4 B	¥ 8 B	¥ 5 B	¥ 4 B
Net income	¥ 1 B	¥ 6 B	¥ 6 B	¥ 3 B	¥ 7 B
Consolidated :Cash flow statement (C/F) Consolidated | Non-Consolidated | Small | Large
U-Chart(pie chart)	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Operating CF Investment CF Financial CF Foreign Exchange Effects Net Change in Cash	*IN(*Right half), OUT(*Left half), BALANCE(*Net Change in Cash)
	[CF] 2009-03-31  *  OCF: ¥ 8 B  *  Cash: ¥ +1 B	[CF] 2010-03-31  *  OCF: ¥ 19 B  *  Cash: ¥ +5 B	[CF] 2011-03-31  *  OCF: ¥ 16 B  *  Cash: ¥ +48 M	[CF] 2012-03-31  *  OCF: ¥ 7 B  *  Cash: ¥ +2 B	[CF] 2013-03-31  *  OCF: ¥ 14 B  *  Cash: ¥ +3 B
Financial Statement Details	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Operating CF	¥ 8 B	¥ 19 B	¥ 16 B	¥ 7 B	¥ 14 B
Investment CF	¥ -4 B	¥ -12 B	¥ -10 B	¥ -4 B	¥ -11 B
Financial CF	¥ -1 B	¥ -2 B	¥ -5 B	¥ -964 M	¥ 173 M
Foreign Exchange Effects	¥ -1 B	¥ 64 M	¥ -460 M	¥ -163 M	¥ 739 M
Net Change in Cash	¥ 1 B	¥ 5 B	¥ 48 M	¥ 2 B	¥ 3 B
Consolidated :Shareowners' equity (S/S) Consolidated | Non-Consolidated | Small | Large
U-Chart(pie chart)	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Issuance of new shares Dividends from surplus Net income Purchase of treasury stock Other Change in Stockholders Equity Other Change in Net Assets Net Change in Net Assets	*IN(*Right half), OUT(*Left half), BALANCE(*Net Change in Net Assets)
	[SS] 2009-03-31  *  Income: ¥ 1 B  *  Net: ¥ -5 B	[SS] 2010-03-31  *  Income: ¥ 6 B  *  Net: ¥ +6 B	[SS] 2011-03-31  *  Income: ¥ 6 B  *  Net: ¥ +3 B	[SS] 2012-03-31  *  Income: ¥ 3 B  *  Net: ¥ +1 B	[SS] 2013-03-31  *  Income: ¥ 7 B  *  Net: ¥ +8 B
Financial Statement Details	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Issuance of new shares	-	-	-	-	-
Dividends from surplus	¥ -2 B	¥ -1 B	¥ -2 B	¥ -2 B	¥ -2 B
Net income	¥ 1 B	¥ 6 B	¥ 6 B	¥ 3 B	¥ 7 B
Purchase of treasury stock	¥ -44 M	¥ -2 M	¥ -1 M	-	-
Other Change in Stockholders Equity	¥ -61 M	¥ -23 M	¥ 60 M	¥ 57 M	¥ 94 M
Other Change in Net Assets	¥ -4 B	¥ 1 B	¥ -1 B	¥ 237 M	¥ 3 B
Net Change in Net Assets	¥ -5 B	¥ 6 B	¥ 3 B	¥ 1 B	¥ 8 B

Non-Consolidated :Balance sheet (B/S) Consolidated | Non-Consolidated | Small | Large
U-Chart(pie chart)	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Cash etc. Other Current Assets Tangible Assets Intangible Assets Investment etc. Current Liabilities Fixed Liabilities Capital stock Capital surplus etc.	*IN(*Right half), OUT(*Left half), BALANCE(*Net Assets)
	[BS] 2009-03-31  *  Total: ¥ 153 B  *  Net: ¥ 102 B  (Ratio: 66.42%)	[BS] 2010-03-31  *  Total: ¥ 165 B  *  Net: ¥ 107 B  (Ratio: 65.01%)	[BS] 2011-03-31  *  Total: ¥ 168 B  *  Net: ¥ 110 B  (Ratio: 65.60%)	[BS] 2012-03-31  *  Total: ¥ 170 B  *  Net: ¥ 110 B  (Ratio: 65.24%)	[BS] 2013-03-31  *  Total: ¥ 171 B  *  Net: ¥ 114 B  (Ratio: 66.64%)
Financial Statement Details	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Cash etc.	¥ 12 B	¥ 16 B	¥ 16 B	¥ 17 B	-
Other Current Assets	¥ 50 B	¥ 57 B	¥ 63 B	¥ 64 B	-
Tangible Assets	¥ 60 B	¥ 58 B	¥ 56 B	¥ 56 B	-
Intangible Assets	¥ 2 B	¥ 3 B	¥ 3 B	¥ 2 B	-
Investment etc.	¥ 27 B	¥ 29 B	¥ 28 B	¥ 28 B	¥ 171 B
Total Assets	¥ 153 B	¥ 165 B	¥ 168 B	¥ 170 B	¥ 171 B
Current Liabilities	¥ 32 B	¥ 34 B	¥ 34 B	¥ 41 B	¥ 57 B
Fixed Liabilities	¥ 19 B	¥ 23 B	¥ 23 B	¥ 18 B	-
Capital stock	¥ 22 B	¥ 22 B	¥ 22 B	¥ 22 B	-
Capital surplus etc.	¥ 79 B	¥ 84 B	¥ 87 B	¥ 88 B	¥ 114 B
Liabilities and net assets	¥ 153 B	¥ 165 B	¥ 168 B	¥ 170 B	¥ 171 B
Non-Consolidated :Income statement (P/L) Consolidated | Non-Consolidated | Small | Large
U-Chart(pie chart)	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Sales Cost of Sales Other income SG&A Other expenses Net income	*IN(*Right half), OUT(*Left half), BALANCE(*Net Income)
	[PL] 2009-03-31  *  Sales: ¥ 125 B  *  Income: ¥ 696 M  (Ratio: 0.56%)	[PL] 2010-03-31  *  Sales: ¥ 112 B  *  Income: ¥ 5 B  (Ratio: 5.05%)	[PL] 2011-03-31  *  Sales: ¥ 122 B  *  Income: ¥ 5 B  (Ratio: 4.44%)	[PL] 2012-03-31  *  Sales: ¥ 113 B  *  Income: ¥ 2 B  (Ratio: 1.97%)	[PL] 2013-03-31  *  Sales: ¥ 113 B  *  Income: ¥ 4 B  (Ratio: 4.19%)
Financial Statement Details	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Sales	¥ 125 B	¥ 112 B	¥ 122 B	¥ 113 B	¥ 113 B
Cost of Sales	¥ 101 B	¥ 84 B	¥ 90 B	¥ 88 B	¥ 108 B
Gross profit	¥ 23 B	¥ 27 B	¥ 31 B	¥ 24 B	¥ 4 B
Other income	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	-
SG&A	¥ 19 B	¥ 19 B	¥ 20 B	¥ 19 B	-
Other expenses	¥ 5 B	¥ 3 B	¥ 7 B	¥ 4 B	-
Net income	¥ 696 M	¥ 5 B	¥ 5 B	¥ 2 B	¥ 4 B
Non-Consolidated :Shareowners' equity (S/S) Consolidated | Non-Consolidated | Small | Large
U-Chart(pie chart)	2009-03-31	2010-03-31	2011-03-31	2012-03-31
Issuance of new shares Dividends from surplus Net income Purchase of treasury stock Other Change in Stockholders Equity Other Change in Net Assets Net Change in Net Assets	*IN(*Right half), OUT(*Left half), BALANCE(*Net Change in Net Assets)
	[SS] 2009-03-31  *  Income: ¥ 696 M  *  Net: ¥ -4 B	[SS] 2010-03-31  *  Income: ¥ 5 B  *  Net: ¥ +5 B	[SS] 2011-03-31  *  Income: ¥ 5 B  *  Net: ¥ +2 B	[SS] 2012-03-31  *  Income: -  *  Net: -
Financial Statement Details	2009-03-31	2010-03-31	2011-03-31	2012-03-31
Issuance of new shares	-	-	-	-
Dividends from surplus	¥ -2 B	¥ -1 B	¥ -2 B	-
Net income	¥ 696 M	¥ 5 B	¥ 5 B	-
Purchase of treasury stock	¥ -2 M	¥ -2 M	¥ -1 M	-
Other Change in Stockholders Equity	¥ -1 M	¥ -1 M	¥ 61 M	¥ 58 M
Other Change in Net Assets	¥ -2 B	¥ 1 B	¥ -327 M	-
Net Change in Net Assets	¥ -4 B	¥ 5 B	¥ 2 B	-

---

Consolidated :Balance sheet (BS) Consolidated | Non-Consolidated Balance sheet | Income statement | Cash flow statement | Shareowners' equity
Consolidated :Balance sheet (Annual )	2008-03-31	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Net assets	¥ 122 B	¥ 116 B	¥ 123 B	¥ 126 B	¥ 128 B	¥ 137 B
Cash and deposits	¥ 13 B	¥ 19 B	¥ 24 B	¥ 25 B	¥ 24 B	¥ 28 B
Notes and accounts receivable-trade	¥ 43 B	¥ 32 B	¥ 36 B	¥ 38 B	¥ 40 B	¥ 39 B
Short-term investment securities	¥ 5 B	¥ 229 M	¥ 6 B	¥ 9 B	¥ 7 B	¥ 7 B
Merchandise and finished goods		¥ 15 B	¥ 11 B	¥ 12 B	¥ 14 B	¥ 17 B
Raw materials and supplies		¥ 12 B	¥ 12 B	¥ 13 B	¥ 13 B	¥ 13 B
Work in process		¥ 4 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 4 B
Deferred tax assets	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Allowance for doubtful accounts	¥ -468 M	¥ -385 M	¥ -287 M	¥ -217 M	¥ -218 M	¥ -307 M
Other	¥ 4 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 4 B	¥ 4 B
Current assets	¥ 100 B	¥ 88 B	¥ 99 B	¥ 106 B	¥ 110 B	¥ 116 B
Buildings and structures	¥ 49 B	¥ 49 B	¥ 49 B	¥ 49 B	¥ 50 B	¥ 53 B
Accumulated depreciation	¥ -28 B	¥ -29 B	¥ -30 B	¥ -31 B	¥ -32 B	¥ -32 B
Buildings and structures, net	¥ 20 B	¥ 19 B	¥ 19 B	¥ 18 B	¥ 18 B	¥ 20 B
Machinery, equipment and vehicles	¥ 94 B	¥ 94 B	¥ 97 B	¥ 98 B	¥ 102 B	¥ 108 B
Accumulated depreciation	¥ -69 B	¥ -70 B	¥ -74 B	¥ -77 B	¥ -80 B	¥ -85 B
Machinery, equipment and vehicles, net	¥ 24 B	¥ 24 B	¥ 23 B	¥ 21 B	¥ 21 B	¥ 22 B
Land	¥ 20 B	¥ 20 B	¥ 20 B	¥ 20 B	¥ 20 B	¥ 20 B
Lease assets		¥ 849 M	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Accumulated depreciation		¥ -139 M	¥ -301 M	¥ -411 M	¥ -580 M	¥ -797 M
Lease assets, net		¥ 709 M	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Construction in progress	¥ 2 B	¥ 1 B	¥ 1 B	¥ 2 B	¥ 2 B	¥ 2 B
Other	¥ 19 B	¥ 20 B	¥ 20 B	¥ 20 B	¥ 21 B	¥ 22 B
Accumulated depreciation	¥ -14 B	¥ -15 B	¥ -15 B	¥ -16 B	¥ -17 B	¥ -18 B
Other, net	¥ 4 B	¥ 4 B	¥ 4 B	¥ 4 B	¥ 3 B	¥ 4 B
Property, plant and equipment	¥ 73 B	¥ 71 B	¥ 69 B	¥ 68 B	¥ 68 B	¥ 71 B
Software	¥ 567 M	¥ 542 M	¥ 595 M	¥ 2 B	¥ 2 B	¥ 1 B
Goodwill					-	¥ 245 M
Lease assets		¥ 27 M	¥ 50 M	¥ 52 M	¥ 105 M	¥ 111 M
Other	¥ 703 M	¥ 734 M	¥ 828 M	¥ 859 M	¥ 949 M	¥ 1 B
Intangible assets	¥ 1 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B
Investment securities	¥ 32 B	¥ 21 B	¥ 24 B	¥ 23 B	¥ 23 B	¥ 24 B
Long-term loans receivable	¥ 443 M	¥ 1 B	¥ 338 M	¥ 351 M	¥ 481 M	¥ 701 M
Deferred tax assets	¥ 1 B	¥ 3 B	¥ 2 B	¥ 3 B	¥ 2 B	¥ 2 B
Other	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 2 B	¥ 3 B
Allowance for doubtful accounts	¥ -1 B	¥ -1 B	¥ -412 M	¥ -411 M	¥ -353 M	¥ -333 M
Investments and other assets	¥ 37 B	¥ 28 B	¥ 30 B	¥ 29 B	¥ 28 B	¥ 30 B
Noncurrent assets	¥ 112 B	¥ 103 B	¥ 103 B	¥ 100 B	¥ 100 B	¥ 106 B
Assets	¥ 212 B	¥ 192 B	¥ 203 B	¥ 207 B	¥ 210 B	¥ 222 B
Notes and accounts payable-trade	¥ 34 B	¥ 27 B	¥ 28 B	¥ 31 B	¥ 33 B	¥ 32 B
Lease obligations		¥ 117 M	¥ 221 M	¥ 202 M	¥ 241 M	¥ 308 M
Provision for bonuses	¥ 2 B	¥ 1 B	¥ 1 B	¥ 2 B	¥ 1 B	¥ 1 B
Provision for directors' bonuses	¥ 57 M	¥ 16 M	¥ 47 M	¥ 39 M	¥ 39 M	¥ 48 M
Income taxes payable	¥ 3 B	¥ 290 M	¥ 2 B	¥ 2 B	¥ 1 B	¥ 1 B
Short-term loans payable	¥ 15 B	¥ 14 B	¥ 13 B	¥ 11 B	¥ 13 B	¥ 13 B
Other	¥ 9 B	¥ 7 B	¥ 5 B	¥ 4 B	¥ 10 B	¥ 5 B
Current liabilities	¥ 64 B	¥ 52 B	¥ 52 B	¥ 53 B	¥ 60 B	¥ 55 B
Long-term loans payable	¥ 9 B	¥ 6 B	¥ 10 B	¥ 10 B	¥ 4 B	¥ 13 B
Provision for retirement benefits	¥ 8 B	¥ 8 B	¥ 8 B	¥ 8 B	¥ 8 B	¥ 9 B
Provision for directors' retirement benefits	¥ 485 M	¥ 174 M	¥ 177 M	¥ 168 M	¥ 124 M	¥ 106 M
Lease obligations		¥ 578 M	¥ 1 B	¥ 777 M	¥ 932 M	¥ 926 M
Deferred tax liabilities	¥ 319 M	¥ 420 M	¥ 475 M	¥ 470 M	¥ 470 M	¥ 546 M
Deferred tax liabilities for land revaluation	¥ 4 B	¥ 4 B	¥ 4 B	¥ 4 B	¥ 4 B	¥ 4 B
Other	¥ 1 B	¥ 2 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Noncurrent liabilities	¥ 25 B	¥ 23 B	¥ 27 B	¥ 27 B	¥ 21 B	¥ 30 B
Liabilities	¥ 90 B	¥ 76 B	¥ 80 B	¥ 80 B	¥ 82 B	¥ 85 B
Capital stock	¥ 22 B	¥ 22 B	¥ 22 B	¥ 22 B	¥ 22 B	¥ 22 B
Capital surplus	¥ 19 B	¥ 19 B	¥ 19 B	¥ 19 B	¥ 19 B	¥ 19 B
Retained earnings	¥ 70 B	¥ 69 B	¥ 73 B	¥ 78 B	¥ 80 B	¥ 85 B
Treasury stock	¥ -176 M	¥ -220 M	¥ -223 M	¥ -224 M	¥ -224 M	¥ -224 M
Shareholders' equity	¥ 112 B	¥ 111 B	¥ 116 B	¥ 121 B	¥ 122 B	¥ 128 B
Valuation difference on available-for-sale securities	¥ 2 B	¥ -255 M	¥ 1 B	¥ 1 B	¥ 984 M	¥ 1 B
Revaluation reserve for land	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B
Foreign currency translation adjustment	¥ 669 M	¥ -1 B	¥ -1 B	¥ -1 B	¥ -2 B	¥ -746 M
Valuation and translation adjustments	¥ 6 B	¥ 1 B	¥ 3 B	¥ 2 B	¥ 2 B	¥ 4 B
Minority interests	¥ 2 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 4 B
Liabilities and net assets	¥ 212 B	¥ 192 B	¥ 203 B	¥ 207 B	¥ 210 B	¥ 222 B
Software in progress		¥ 1 B	¥ 2 B	¥ 59 M	¥ 157 M
Provision for loss on guarantees		¥ 349 M
Inventories	¥ 31 B
Consolidated :Income statement (PL) Consolidated | Non-Consolidated Balance sheet | Income statement | Cash flow statement | Shareowners' equity
Consolidated :Income statement (Annual )	2008-03-31	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Net sales	¥ 191 B	¥ 176 B	¥ 159 B	¥ 178 B	¥ 170 B	¥ 184 B
Operating income	¥ 16 B	¥ 6 B	¥ 10 B	¥ 14 B	¥ 8 B	¥ 9 B
Ordinary income	¥ 15 B	¥ 6 B	¥ 10 B	¥ 14 B	¥ 8 B	¥ 11 B
Net income	¥ 8 B	¥ 1 B	¥ 6 B	¥ 6 B	¥ 3 B	¥ 7 B
Comprehensive income				¥ 5 B	¥ 4 B	¥ 10 B
Cost of sales	¥ 149 B	¥ 143 B	¥ 123 B	¥ 135 B	¥ 134 B	¥ 146 B
Selling, general and administrative expenses	¥ 26 B	¥ 25 B	¥ 25 B	¥ 27 B	¥ 27 B	¥ 28 B
Gross profit	¥ 42 B	¥ 32 B	¥ 36 B	¥ 42 B	¥ 35 B	¥ 38 B
Interest income	¥ 149 M	¥ 122 M	¥ 140 M	¥ 97 M	¥ 108 M	¥ 115 M
Dividends income	¥ 387 M	¥ 431 M	¥ 285 M	¥ 293 M	¥ 321 M	¥ 318 M
Equity in earnings of affiliates	¥ 411 M		¥ 135 M	¥ 440 M	¥ 204 M	¥ 883 M
Foreign exchange gains					-	¥ 490 M
Other	¥ 320 M	¥ 511 M	¥ 377 M	¥ 316 M	¥ 465 M	¥ 580 M
Non-operating income	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 2 B
Interest expenses	¥ 612 M	¥ 519 M	¥ 514 M	¥ 380 M	¥ 378 M	¥ 414 M
Foreign exchange losses	¥ 532 M	¥ 845 M	¥ 115 M	¥ 537 M	¥ 96 M	-
Loss on abandonment of inventories	¥ 397 M			¥ 77 M	¥ 91 M	¥ 93 M
Other	¥ 746 M	¥ 492 M	¥ 398 M	¥ 437 M	¥ 249 M	¥ 412 M
Non-operating expenses	¥ 2 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 814 M	¥ 919 M
Extraordinary income	¥ 708 M	¥ 422 M	¥ 294 M	¥ 110 M	¥ 148 M	-
Loss on disaster				¥ 1 B	¥ 305 M	-
Loss on abandonment of noncurrent assets	¥ 630 M	¥ 543 M	¥ 580 M	¥ 367 M	¥ 387 M	¥ 317 M
Loss on valuation of investment securities	¥ 49 M	¥ 621 M	¥ 4 M	¥ 576 M	¥ 397 M	¥ 74 M
Extraordinary loss	¥ 1 B	¥ 3 B	¥ 584 M	¥ 3 B	¥ 2 B	¥ 535 M
Income before income taxes	¥ 14 B	¥ 3 B	¥ 9 B	¥ 11 B	¥ 6 B	¥ 10 B
Income taxes	¥ 5 B	¥ 1 B	¥ 2 B	¥ 4 B	¥ 2 B	¥ 2 B
Income taxes-current	¥ 5 B	¥ 1 B	¥ 2 B	¥ 4 B	¥ 2 B	¥ 2 B
Income taxes-deferred	¥ -250 M	¥ 76 M	¥ 36 M	¥ -103 M	¥ 30 M	¥ -27 M
Income before minority interests				¥ 7 B	¥ 4 B	¥ 7 B
Minority interests in income	¥ 401 M	¥ 388 M	¥ 283 M	¥ 220 M	¥ 267 M	¥ 277 M
Valuation difference on available-for-sale securities				¥ -269 M	-	¥ 784 M
Foreign currency translation adjustment				¥ -914 M	¥ -474 M	¥ 1 B
Share of other comprehensive income of associates accounted for using equity method				¥ -8 M	¥ -17 M	¥ 101 M
Other comprehensive income				¥ -1 B	¥ 86 M	¥ 2 B
Comprehensive income attributable to owners of the parent				¥ 5 B	¥ 3 B	¥ 10 B
Comprehensive income attributable to minority interests				¥ 44 M	¥ 181 M	¥ 634 M
Insurance income				¥ 110 M	-
Impairment loss		¥ 794 M		¥ 104 M	-
Loss on adjustment for changes of accounting standard for asset retirement obligations				¥ 101 M	-
Subsidy income			¥ 156 M
Reversal of allowance for doubtful accounts			¥ 294 M
Equity in losses of affiliates		¥ 89 M
Gain on sales of investment securities	¥ 249 M	¥ 422 M
Loss on sales of stocks of subsidiaries and affiliates		¥ 29 M
Loss on valuation of investments in capital of subsidiaries and affiliates	¥ 218 M	¥ 561 M
Provision of allowance for doubtful accounts for subsidiaries and affiliates		¥ 242 M
Loss on valuation of other investments		¥ 13 M
Provision for loss on guarantees		¥ 349 M
Gain on sales of subsidiaries and affiliates' stocks	¥ 111 M
Gain on insurance adjustment	¥ 347 M
Loss on transfer of business	¥ 155 M
Consolidated :Cash flow statement (CF) Consolidated | Non-Consolidated Balance sheet | Income statement | Cash flow statement | Shareowners' equity
Consolidated :Cash flow statement (Annual )	2008-03-31	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Subtotal	¥ 20 B	¥ 13 B	¥ 20 B	¥ 19 B	¥ 10 B	¥ 18 B
Depreciation and amortization	¥ 7 B	¥ 7 B	¥ 7 B	¥ 8 B	¥ 8 B	¥ 8 B
Interest and dividends income	¥ -536 M	¥ -553 M	¥ -426 M	¥ -391 M	¥ -430 M	¥ -433 M
Interest expenses	¥ 612 M	¥ 519 M	¥ 514 M	¥ 380 M	¥ 378 M	¥ 414 M
Equity in (earnings) losses of affiliates	¥ -411 M	¥ 89 M	¥ -135 M	¥ -440 M	¥ -204 M	¥ -883 M
Decrease (increase) in notes and accounts receivable-trade	¥ -650 M	¥ 10 B	¥ -3 B	¥ -2 B	¥ -2 B	¥ 1 B
Decrease (increase) in inventories	¥ -2 B	¥ -1 B	¥ 5 B	¥ -1 B	¥ -3 B	¥ -1 B
Increase (decrease) in notes and accounts payable-trade	¥ 639 M	¥ -9 B	¥ 536 M	¥ 3 B	¥ 2 B	¥ -1 B
Loss (gain) on valuation of investment securities	¥ 49 M	¥ 621 M		¥ 576 M	¥ 397 M	¥ 74 M
Loss on abandonment of noncurrent assets	¥ 630 M	¥ 543 M	¥ 580 M	¥ 367 M	¥ 387 M	¥ 317 M
Other, net	¥ 911 M	¥ -312 M	¥ -342 M	¥ -461 M	¥ -939 M	¥ 582 M
Interest and dividends income received	¥ 681 M	¥ 708 M	¥ 512 M	¥ 750 M	¥ 589 M	¥ 585 M
Interest expenses paid	¥ -612 M	¥ -523 M	¥ -504 M	¥ -378 M	¥ -373 M	¥ -412 M
Income taxes paid	¥ -6 B	¥ -4 B	¥ -1 B	¥ -3 B	¥ -3 B	¥ -2 B
Net cash provided by (used in) operating activities	¥ 14 B	¥ 8 B	¥ 19 B	¥ 16 B	¥ 7 B	¥ 14 B
Purchase of short-term investment securities			¥ -9 B	¥ -20 B	¥ -21 B	¥ -23 B
Purchase of property, plant and equipment	¥ -10 B	¥ -8 B	¥ -4 B	¥ -6 B	¥ -7 B	¥ -10 B
Proceeds from sales and redemption of securities		¥ 2 B	¥ 5 B	¥ 18 B	¥ 24 B	¥ 23 B
Purchase of intangible assets	¥ -495 M	¥ -1 B	¥ -1 B	¥ -638 M	¥ -487 M	¥ -549 M
Purchase of stocks of subsidiaries and affiliates	¥ -184 M			-	¥ -414 M	¥ -376 M
Payments for transfer of business					-	¥ -1 B
Other, net	¥ -659 M	¥ -306 M	¥ -1 B	¥ -551 M	¥ 1 B	¥ 483 M
Net cash provided by (used in) investing activities	¥ -14 B	¥ -4 B	¥ -12 B	¥ -10 B	¥ -4 B	¥ -11 B
Proceeds from long-term loans payable	¥ 297 M	¥ 618 M	¥ 9 B	¥ 214 M	¥ 247 M	¥ 8 B
Repayment of long-term loans payable	¥ -831 M	¥ -749 M	¥ -8 B	¥ -548 M	¥ -440 M	¥ -5 B
Cash dividends paid	¥ -2 B	¥ -2 B	¥ -1 B	¥ -2 B	¥ -2 B	¥ -2 B
Net increase (decrease) in short-term loans payable	¥ 641 M	¥ 231 M	¥ -1 B	¥ -2 B	¥ 1 B	¥ -392 M
Cash dividends paid to minority shareholders	¥ -59 M	¥ -72 M	¥ -75 M	¥ -45 M	¥ -57 M	¥ -105 M
Other, net	¥ -43 M	¥ 375 M	¥ -132 M	¥ -239 M	¥ -200 M	¥ -10 M
Net cash provided by (used in) financing activities	¥ -2 B	¥ -1 B	¥ -2 B	¥ -5 B	¥ -964 M	¥ 173 M
Effect of exchange rate change on cash and cash equivalents	¥ -218 M	¥ -1 B	¥ 64 M	¥ -460 M	¥ -163 M	¥ 739 M
Net increase (decrease) in cash and cash equivalents	¥ -2 B	¥ 1 B	¥ 5 B	¥ 48 M	¥ 2 B	¥ 3 B
Cash and cash equivalents	¥ 16 B	¥ 17 B	¥ 23 B	¥ 23 B	¥ 25 B	¥ 29 B
Income taxes refund			¥ 425 M
Increase in cash and cash equivalents from newly consolidated subsidiary	¥ 84 M	¥ 144 M	¥ 183 M
Impairment loss		¥ 794 M
Increase (decrease) in allowance for doubtful accounts	¥ 116 M	¥ 236 M
Foreign exchange losses (gains)	¥ 128 M	¥ 427 M
Loss (gain) on sales of investment securities	¥ -242 M	¥ -422 M
Increase (decrease) in provision for retirement benefits	¥ 45 M	¥ -62 M
Purchase of investment securities	¥ -3 B	¥ -664 M
Proceeds from sales of investment securities	¥ 736 M	¥ 5 B
Proceeds from sales of stocks of subsidiaries and affiliates	¥ 194 M	¥ 120 M
Loss (gain) on sales of stocks of subsidiaries and affiliates	¥ -111 M
Loss (gain) on sales of noncurrent assets	¥ 9 M
Proceeds from issuance of common stock	¥ 211 M
Consolidated :Shareowners' equity (SS) Consolidated | Non-Consolidated Balance sheet | Income statement | Cash flow statement | Shareowners' equity
Consolidated :Shareowners' equity (Annual )	2008-03-31	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Total changes of items during the period	¥ 105 M				-	-
Total changes of items during the period	¥ 105 M				-	-
Reversal of revaluation reserve for land				¥ 62 M	¥ 57 M	¥ 94 M
Dividends from surplus	¥ -2 B	¥ -2 B	¥ -1 B	¥ -2 B	¥ -2 B	¥ -2 B
Total changes of items during the period	¥ 6 B	¥ -1 B	¥ 4 B	¥ 4 B	¥ 1 B	¥ 5 B
Purchase of treasury stock	¥ -2 M	¥ -44 M	¥ -2 M	¥ -1 M	-	-
Total changes of items during the period	¥ -2 M	¥ -44 M	¥ -2 M	¥ -1 M	-	-
Dividends from surplus	¥ -2 B	¥ -2 B	¥ -1 B	¥ -2 B	¥ -2 B	¥ -2 B
Net income	¥ 8 B	¥ 1 B	¥ 6 B	¥ 6 B	¥ 3 B	¥ 7 B
Purchase of treasury stock	¥ -2 M	¥ -44 M	¥ -2 M	¥ -1 M	-	-
Reversal of revaluation reserve for land				¥ 62 M	¥ 57 M	¥ 94 M
Total changes of items during the period	¥ 6 B	¥ -1 B	¥ 4 B	¥ 4 B	¥ 1 B	¥ 5 B
Net changes of items other than shareholders' equity	¥ -3 B	¥ -2 B	¥ 1 B	¥ -277 M	¥ -16 M	¥ 883 M
Total changes of items during the period	¥ -3 B	¥ -2 B	¥ 1 B	¥ -277 M	¥ -16 M	¥ 883 M
Net changes of items other than shareholders' equity				¥ -62 M	¥ 520 M	¥ -94 M
Total changes of items during the period				¥ -62 M	¥ 520 M	¥ -94 M
Net changes of items other than shareholders' equity	¥ -137 M	¥ -2 B	¥ 337 M	¥ -738 M	¥ -388 M	¥ 1 B
Total changes of items during the period	¥ -137 M	¥ -2 B	¥ 337 M	¥ -738 M	¥ -388 M	¥ 1 B
Net changes of items other than shareholders' equity	¥ -3 B	¥ -4 B	¥ 1 B	¥ -1 B	¥ 115 M	¥ 2 B
Total changes of items during the period	¥ -3 B	¥ -4 B	¥ 1 B	¥ -1 B	¥ 115 M	¥ 2 B
Net changes of items other than shareholders' equity	¥ 150 M	¥ 470 M	¥ 20 M	¥ -1 M	¥ 122 M	¥ 796 M
Total changes of items during the period	¥ 150 M	¥ 470 M	¥ 20 M	¥ -1 M	¥ 122 M	¥ 796 M
Dividends from surplus	¥ -2 B	¥ -2 B	¥ -1 B	¥ -2 B	¥ -2 B	¥ -2 B
Net income	¥ 8 B	¥ 1 B	¥ 6 B	¥ 6 B	¥ 3 B	¥ 7 B
Purchase of treasury stock	¥ -2 M	¥ -44 M	¥ -2 M	¥ -1 M	-	-
Net changes of items other than shareholders' equity	¥ -3 B	¥ -4 B	¥ 1 B	¥ -1 B	¥ 237 M	¥ 3 B
Reversal of revaluation reserve for land				¥ 62 M	¥ 57 M	¥ 94 M
Total changes of items during the period	¥ 2 B	¥ -5 B	¥ 6 B	¥ 3 B	¥ 1 B	¥ 8 B
Issuance of new shares	¥ 105 M
Issuance of new shares	¥ 105 M
Issuance of new shares	¥ 211 M
Issuance of new shares	¥ 211 M

Non-Consolidated :Balance sheet (BS) Consolidated | Non-Consolidated Balance sheet | Income statement | Shareowners' equity
Non-Consolidated :Balance sheet (Annual )	2008-03-31	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Net assets	¥ 106 B	¥ 102 B	¥ 107 B	¥ 110 B	¥ 110 B
Cash and deposits	¥ 5 B	¥ 12 B	¥ 16 B	¥ 16 B	¥ 17 B
Notes receivable-trade	¥ 3 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 3 B
Accounts receivable-trade	¥ 30 B	¥ 20 B	¥ 24 B	¥ 24 B	¥ 26 B
Short-term investment securities	¥ 5 B	¥ 129 M	¥ 6 B	¥ 9 B	¥ 7 B
Merchandise and finished goods		¥ 9 B	¥ 6 B	¥ 7 B	¥ 8 B
Raw materials and supplies		¥ 10 B	¥ 9 B	¥ 10 B	¥ 10 B
Work in process	¥ 3 B	¥ 4 B	¥ 3 B	¥ 3 B	¥ 3 B
Prepaid expenses	¥ 141 M	¥ 145 M	¥ 153 M	¥ 167 M	¥ 163 M
Deferred tax assets	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Accounts receivable-other	¥ 2 B	¥ 1 B	¥ 1 B	¥ 2 B	¥ 2 B
Allowance for doubtful accounts	¥ -114 M	¥ -74 M	¥ -60 M	¥ -32 M	¥ -36 M
Other	¥ 895 M	¥ 1 B	¥ 1 B	¥ 1 B	¥ 2 B
Current assets	¥ 73 B	¥ 63 B	¥ 74 B	¥ 79 B	¥ 81 B
Buildings	¥ 29 B	¥ 29 B	¥ 29 B	¥ 30 B	¥ 30 B
Accumulated depreciation	¥ -15 B	¥ -16 B	¥ -16 B	¥ -17 B	¥ -17 B
Buildings, net	¥ 13 B	¥ 13 B	¥ 13 B	¥ 12 B	¥ 12 B
Structures	¥ 11 B	¥ 12 B	¥ 12 B	¥ 12 B	¥ 12 B
Accumulated depreciation	¥ -9 B	¥ -9 B	¥ -9 B	¥ -10 B	¥ -10 B
Structures, net	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B
Machinery and equipment	¥ 81 B	¥ 83 B	¥ 85 B	¥ 86 B	¥ 89 B
Accumulated depreciation	¥ -60 B	¥ -62 B	¥ -65 B	¥ -67 B	¥ -70 B
Machinery and equipment, net	¥ 21 B	¥ 21 B	¥ 19 B	¥ 18 B	¥ 18 B
Vehicles	¥ 294 M	¥ 297 M	¥ 308 M	¥ 309 M	¥ 301 M
Accumulated depreciation	¥ -248 M	¥ -260 M	¥ -268 M	¥ -271 M	¥ -273 M
Vehicles, net	¥ 46 M	¥ 36 M	¥ 40 M	¥ 37 M	¥ 27 M
Tools, furniture and fixtures	¥ 15 B	¥ 16 B	¥ 16 B	¥ 17 B	¥ 17 B
Accumulated depreciation	¥ -12 B	¥ -13 B	¥ -13 B	¥ -14 B	¥ -15 B
Tools, furniture and fixtures, net	¥ 3 B	¥ 3 B	¥ 2 B	¥ 2 B	¥ 2 B
Land	¥ 18 B	¥ 18 B	¥ 18 B	¥ 18 B	¥ 18 B
Lease assets		¥ 86 M	¥ 160 M	¥ 257 M	¥ 562 M
Accumulated depreciation		¥ -8 M	¥ -39 M	¥ -85 M	¥ -171 M
Lease assets, net		¥ 77 M	¥ 121 M	¥ 171 M	¥ 390 M
Construction in progress	¥ 1 B	¥ 1 B	¥ 933 M	¥ 1 B	¥ 2 B
Property, plant and equipment	¥ 60 B	¥ 60 B	¥ 58 B	¥ 56 B	¥ 56 B
Patent right	¥ 249 M	¥ 302 M	¥ 333 M	¥ 394 M	¥ 500 M
Leasehold right	¥ 104 M	¥ 104 M	¥ 104 M	¥ 104 M	¥ 104 M
Software	¥ 459 M	¥ 380 M	¥ 452 M	¥ 2 B	¥ 1 B
Lease assets		¥ 27 M	¥ 28 M	¥ 27 M	¥ 18 M
Other	¥ 79 M	¥ 80 M	¥ 83 M	¥ 131 M	¥ 231 M
Intangible assets	¥ 892 M	¥ 2 B	¥ 3 B	¥ 3 B	¥ 2 B
Investment securities	¥ 20 B	¥ 10 B	¥ 12 B	¥ 11 B	¥ 11 B
Stocks of subsidiaries and affiliates	¥ 8 B	¥ 8 B	¥ 8 B	¥ 8 B	¥ 9 B
Investments in capital of subsidiaries and affiliates	¥ 2 B	¥ 2 B	¥ 3 B	¥ 3 B	¥ 3 B
Long-term loans receivable	¥ 6 M	¥ 1 M	¥ 1 M		-
Long-term loans receivable from subsidiaries and affiliates	¥ 1 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B
Long-term loans receivable from employees	¥ 26 M	¥ 23 M	¥ 19 M	¥ 18 M	¥ 22 M
Long-term prepaid expenses	¥ 178 M	¥ 152 M	¥ 107 M	¥ 116 M	¥ 128 M
Deferred tax assets	¥ 1 B	¥ 3 B	¥ 2 B	¥ 2 B	¥ 2 B
Long-term accounts receivable from subsidiaries and affiliates		¥ 80 M	¥ 40 M	¥ 40 M	¥ 40 M
Other	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Allowance for doubtful accounts	¥ -1 B	¥ -2 B	¥ -1 B	¥ -1 B	¥ -1 B
Investments and other assets	¥ 34 B	¥ 27 B	¥ 29 B	¥ 28 B	¥ 28 B
Noncurrent assets	¥ 96 B	¥ 90 B	¥ 90 B	¥ 88 B	¥ 88 B
Assets	¥ 169 B	¥ 153 B	¥ 165 B	¥ 168 B	¥ 170 B
Notes payable-trade	¥ 3 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B
Accounts payable-trade	¥ 21 B	¥ 13 B	¥ 16 B	¥ 17 B	¥ 19 B
Accrued expenses	¥ 3 B	¥ 2 B	¥ 3 B	¥ 3 B	¥ 3 B
Lease obligations		¥ 28 M	¥ 48 M	¥ 70 M	¥ 98 M
Provision for bonuses	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Provision for directors' bonuses	¥ 40 M		¥ 30 M	¥ 20 M	¥ 20 M
Provision for loss on guarantees	¥ 79 M	¥ 610 M	¥ 326 M	¥ 143 M	¥ 67 M
Accounts payable-other	¥ 262 M	¥ 167 M	¥ 554 M	¥ 56 M	¥ 1 B
Income taxes payable	¥ 3 B		¥ 1 B	¥ 1 B	¥ 978 M
Deposits received	¥ 175 M	¥ 225 M	¥ 85 M	¥ 9 M	¥ 3 M
Accounts payable-facilities	¥ 3 B	¥ 3 B		¥ 1 B	¥ 3 B
Short-term loans payable	¥ 5 B	¥ 5 B	¥ 5 B	¥ 4 B	¥ 4 B
Current portion of long-term loans payable	¥ 2 M	¥ 2 B	¥ 1 M	¥ 1 M	¥ 5 B
Other	¥ 180 M	¥ 246 M	¥ 1 B	¥ 118 M	¥ 88 M
Current liabilities	¥ 42 B	¥ 32 B	¥ 34 B	¥ 34 B	¥ 41 B
Long-term loans payable	¥ 7 B	¥ 5 B	¥ 9 B	¥ 9 B	¥ 4 B
Provision for retirement benefits	¥ 7 B	¥ 7 B	¥ 7 B	¥ 7 B	¥ 7 B
Lease obligations		¥ 83 M	¥ 110 M	¥ 142 M	¥ 344 M
Asset retirement obligations				¥ 128 M	¥ 121 M
Long-term deposits received	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Deferred tax liabilities for land revaluation	¥ 4 B	¥ 4 B	¥ 4 B	¥ 4 B	¥ 4 B
Other			¥ 110 M	¥ 84 M	¥ 73 M
Noncurrent liabilities	¥ 21 B	¥ 19 B	¥ 23 B	¥ 23 B	¥ 18 B
Liabilities	¥ 63 B	¥ 51 B	¥ 57 B	¥ 57 B	¥ 59 B
Capital stock	¥ 22 B	¥ 22 B	¥ 22 B	¥ 22 B	¥ 22 B
Legal capital surplus	¥ 19 B	¥ 19 B	¥ 19 B	¥ 19 B	¥ 19 B
Capital surplus	¥ 19 B	¥ 19 B	¥ 19 B	¥ 19 B	¥ 19 B
Legal retained earnings	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Reserve for advanced depreciation of noncurrent assets	¥ 182 M	¥ 178 M	¥ 174 M	¥ 170 M	¥ 179 M
Reserve for dividends	¥ 90 M	¥ 90 M	¥ 90 M	¥ 90 M	¥ 90 M
General reserve	¥ 46 B	¥ 51 B	¥ 51 B	¥ 51 B	¥ 51 B
Retained earnings brought forward	¥ 10 B	¥ 3 B	¥ 7 B	¥ 10 B	¥ 10 B
Retained earnings	¥ 58 B	¥ 56 B	¥ 60 B	¥ 63 B	¥ 63 B
Treasury stock	¥ -161 M	¥ -163 M	¥ -166 M	¥ -167 M	¥ -167 M
Shareholders' equity	¥ 100 B	¥ 99 B	¥ 102 B	¥ 106 B	¥ 106 B
Valuation difference on available-for-sale securities	¥ 2 B	¥ -257 M	¥ 1 B	¥ 958 M	¥ 950 M
Revaluation reserve for land	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B
Valuation and translation adjustments	¥ 5 B	¥ 3 B	¥ 4 B	¥ 4 B	¥ 4 B
Liabilities and net assets	¥ 169 B	¥ 153 B	¥ 165 B	¥ 168 B	¥ 170 B
Software in progress		¥ 1 B	¥ 2 B
Long-term accounts payable-other		¥ 288 M
Finished goods	¥ 8 B
Semi-finished goods	¥ 534 M
Raw materials	¥ 5 B
Supplies	¥ 3 B
Short-term loans receivable	¥ 1 B
Provision for directors' retirement benefits	¥ 311 M
Non-Consolidated :Income statement (PL) Consolidated | Non-Consolidated Balance sheet | Income statement | Shareowners' equity
Non-Consolidated :Income statement (Annual )	2008-03-31	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Net sales	¥ 136 B	¥ 125 B	¥ 112 B	¥ 122 B	¥ 113 B
Operating income	¥ 13 B	¥ 4 B	¥ 8 B	¥ 10 B	¥ 5 B
Ordinary income	¥ 12 B	¥ 4 B	¥ 8 B	¥ 11 B	¥ 5 B
Net income	¥ 7 B	¥ 696 M	¥ 5 B	¥ 5 B	¥ 2 B
Cost of sales	¥ 103 B	¥ 101 B	¥ 84 B	¥ 90 B	¥ 88 B
Cost of purchased goods	¥ 29 B	¥ 24 B	¥ 18 B	¥ 22 B	¥ 21 B
Cost of products manufactured	¥ 74 B	¥ 77 B	¥ 63 B	¥ 68 B	¥ 68 B
Total	¥ 112 B	¥ 110 B	¥ 91 B	¥ 98 B	¥ 96 B
Transfer to other account	¥ 37 M	¥ 9 M	¥ 7 M	¥ 69 M	¥ 68 M
Selling, general and administrative expenses	¥ 19 B	¥ 19 B	¥ 19 B	¥ 20 B	¥ 19 B
Gross profit	¥ 33 B	¥ 23 B	¥ 27 B	¥ 31 B	¥ 24 B
Interest income	¥ 91 M	¥ 82 M	¥ 121 M	¥ 89 M	¥ 92 M
Dividends income	¥ 867 M	¥ 828 M	¥ 577 M	¥ 1 B	¥ 993 M
Other	¥ 171 M	¥ 179 M	¥ 248 M	¥ 224 M	¥ 361 M
Non-operating income	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Interest expenses	¥ 192 M	¥ 196 M	¥ 253 M	¥ 192 M	¥ 175 M
Foreign exchange losses	¥ 483 M	¥ 281 M	¥ 197 M	¥ 321 M	¥ 110 M
Other	¥ 473 M	¥ 206 M	¥ 313 M	¥ 230 M	¥ 146 M
Non-operating expenses	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 806 M
Gain on sales of noncurrent assets				-	¥ 22 M
Reversal of allowance for doubtful accounts			¥ 278 M	¥ 69 M	-
Reversal of provision for loss on guarantees				¥ 183 M	-
Extraordinary income	¥ 478 M	¥ 419 M	¥ 278 M	¥ 252 M	¥ 171 M
Impairment loss				¥ 104 M	-
Loss on disaster				¥ 1 B	¥ 297 M
Loss on abandonment of noncurrent assets	¥ 560 M	¥ 513 M	¥ 556 M	¥ 358 M	¥ 367 M
Loss on valuation of investment securities	¥ 27 M	¥ 608 M	¥ 4 M	¥ 576 M	¥ 383 M
Loss on valuation of other investments		¥ 8 M		¥ 1 M	¥ 4 M
Loss on adjustment for changes of accounting standard for asset retirement obligations				¥ 100 M	-
Extraordinary loss	¥ 1 B	¥ 3 B	¥ 561 M	¥ 3 B	¥ 2 B
Income before income taxes	¥ 11 B	¥ 1 B	¥ 7 B	¥ 8 B	¥ 3 B
Income taxes	¥ 4 B	¥ 967 M	¥ 2 B	¥ 3 B	¥ 1 B
Income taxes-current	¥ 4 B	¥ 929 M	¥ 2 B	¥ 3 B	¥ 1 B
Income taxes-deferred	¥ -100 M	¥ 38 M	¥ 11 M	¥ -79 M	¥ -46 M
Subsidy income			¥ 156 M
Rent income	¥ 88 M	¥ 86 M
Gain on sales of investment securities	¥ 248 M	¥ 419 M
Loss on valuation of stocks of subsidiaries and affiliates	¥ 329 M	¥ 294 M
Loss on sales of stocks of subsidiaries and affiliates		¥ 29 M
Loss on valuation of investments in capital of subsidiaries and affiliates	¥ 218 M	¥ 561 M
Provision of allowance for doubtful accounts for subsidiaries and affiliates	¥ 300 M	¥ 794 M
Provision for loss on guarantees	¥ 79 M	¥ 531 M
Loss on abandonment of inventories	¥ 317 M
Gain on sales of subsidiaries and affiliates' stocks	¥ 229 M
Loss on transfer of business	¥ 155 M
Non-Consolidated :Shareowners' equity (SS) Consolidated | Non-Consolidated Balance sheet | Income statement | Shareowners' equity
Non-Consolidated :Shareowners' equity (Annual )	2008-03-31	2009-03-31	2010-03-31	2011-03-31	2012-03-31
Total changes of items during the period	¥ 105 M				-
Total changes of items during the period	¥ 105 M				-
Total changes of items during the period	¥ 105 M				-
Total changes of items during the period					-
Reversal of reserve for advanced depreciation of noncurrent assets	¥ -30 M	¥ -4 M	¥ -3 M	¥ -3 M	¥ -4 M
Total changes of items during the period	¥ -30 M	¥ -4 M	¥ -3 M	¥ -3 M	¥ 8 M
Total changes of items during the period					-
Total changes of items during the period	¥ 6 B	¥ 5 B			-
Dividends from surplus	¥ -2 B	¥ -2 B	¥ -1 B	¥ -2 B	¥ -2 B
Reversal of reserve for advanced depreciation of noncurrent assets				¥ 3 M	¥ 4 M
Reversal of revaluation reserve for land				¥ 62 M	¥ 57 M
Total changes of items during the period	¥ -1 B	¥ -6 B	¥ 3 B	¥ 3 B	¥ 7 M
Dividends from surplus	¥ -2 B	¥ -2 B	¥ -1 B	¥ -2 B	¥ -2 B
Net income	¥ 7 B	¥ 696 M	¥ 5 B	¥ 5 B	¥ 2 B
Reversal of reserve for advanced depreciation of noncurrent assets				-	-
Reversal of revaluation reserve for land				¥ 62 M	¥ 57 M
Total changes of items during the period	¥ 4 B	¥ -1 B	¥ 3 B	¥ 3 B	¥ 15 M
Purchase of treasury stock	¥ -2 M	¥ -2 M	¥ -2 M	¥ -1 M	-
Total changes of items during the period	¥ -2 M	¥ -2 M	¥ -2 M	¥ -1 M	-
Dividends from surplus	¥ -2 B	¥ -2 B	¥ -1 B	¥ -2 B	¥ -2 B
Net income	¥ 7 B	¥ 696 M	¥ 5 B	¥ 5 B	¥ 2 B
Purchase of treasury stock	¥ -2 M	¥ -2 M	¥ -2 M	¥ -1 M	-
Reversal of revaluation reserve for land				¥ 62 M	¥ 57 M
Total changes of items during the period	¥ 5 B	¥ -1 B	¥ 3 B	¥ 3 B	¥ 15 M
Net changes of items other than shareholders' equity	¥ -3 B	¥ -2 B	¥ 1 B	¥ -265 M	¥ -8 M
Total changes of items during the period	¥ -3 B	¥ -2 B	¥ 1 B	¥ -265 M	¥ -8 M
Net changes of items other than shareholders' equity				¥ -62 M	¥ 520 M
Total changes of items during the period				¥ -62 M	¥ 520 M
Net changes of items other than shareholders' equity	¥ -3 B	¥ -2 B	¥ 1 B	¥ -327 M	¥ 512 M
Total changes of items during the period	¥ -3 B	¥ -2 B	¥ 1 B	¥ -327 M	¥ 512 M
Dividends from surplus	¥ -2 B	¥ -2 B	¥ -1 B	¥ -2 B	¥ -2 B
Net income	¥ 7 B	¥ 696 M	¥ 5 B	¥ 5 B	¥ 2 B
Purchase of treasury stock	¥ -2 M	¥ -2 M	¥ -2 M	¥ -1 M	-
Net changes of items other than shareholders' equity	¥ -3 B	¥ -2 B	¥ 1 B	¥ -327 M	¥ 512 M
Reversal of revaluation reserve for land				¥ 62 M	¥ 57 M
Total changes of items during the period	¥ 1 B	¥ -4 B	¥ 5 B	¥ 2 B	¥ 528 M
Reversal of reserve for reduction entry	¥ 30 M	¥ 4 M	¥ 3 M	¥ 3 M
Provision of general reserve	¥ 6 B	¥ 5 B
Provision of general reserve	¥ -6 B	¥ -5 B
Issuance of new shares	¥ 105 M
Issuance of new shares	¥ 105 M
Issuance of new shares	¥ 105 M
Issuance of new shares	¥ 211 M
Issuance of new shares	¥ 211 M

Free Download

*Free Download Financial Statement dataMember limited service.

[Data] Balance sheet, Income statement, Cash flow statement, Shareowners' equity (*Consolidated or Non-Consolidated. two or more terms)

Sponsored Link

Related Information: ADEKA (Annual )

Statement Type

Annual : ADEKA

First quarter : ADEKA

Second quarter : ADEKA

Third quarter : ADEKA

Analysis Menu

Outline : ADEKA

Statement : ADEKA

Rating : ADEKA

Indicator : ADEKA

Download : ADEKA

Industry Comparison Ranking

Chemicals - EDIUNET Industry Rankings

Chemicals - EDIUNET Credit Rating

Chemicals - EDIUNET Industry Avg

Comparison with a neighboring company

Tokyo - EDIUNET Prefectures

Tokyo荒川区 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/23	Milbon	AA→AAA	2013-12-20
1/17	Kawaguchi Chemical Indu..	BBB→BB	2013-11-30
1/17	SANKEI CHEMICAL	A	2013-11-30
1/15	HOKKO CHEMICAL INDUSTRY	BB→B	2013-11-30
1/15	Daito Pharmaceutical Co .	AA	2013-11-30 (Q2)
1/15	KAWAKAMI PAINT MFG.	B→BB	2013-11-30
1/15	旭化学工業	AA	2013-11-30 (Q1)
1/10	OSAKA ORGANIC CHEMICAL ..	BB→BBB	2013-11-30
1/10	HISAMITSU PHARMACEUTICAL	A	2013-11-30 (Q3)
1/10	AMS Life Science	BBB→BB	2013-11-30 (Q1)

EDIUNET Investment News (Chemicals)

1/23 Chemicals (Milbon:AA→AAA)

1/17 Chemicals (Kawaguchi Chemica..

1/15 Chemicals (HOKKO CHEMICAL IN..

1/10 Chemicals (OSAKA ORGANIC CHE..

1/9 Chemicals (SANKO GOSEI:A)

12/27 Chemicals (Niitaka:A)

12/18 Chemicals (KUMIAI CHEMICAL I..

12/12 Chemicals (IHARA CHEMICAL IN..

12/11 Chemicals (Konoshima Chemica..

12/10 Chemicals (NATOCO:AA)

Company Information

Ticker	Market	Industry	Month	report	Rating
ADEKA	4401	TSE 1st	Chemicals	3	Annual	A

Related Company

東京応化工業 (Sales ¥ 72 B)

Kuraray (Sales ¥ 369 B)

積水樹脂 (Sales ¥ 64 B)

アステラス製薬 (Sales ¥ 1.0 T)

NIPPON KAYAKU (Sales ¥ 128 B)

Sekisui Chemical (Sales ¥ 1.0 T)

Takeda Pharmaceutical (Sales ¥ 1.5 T)

ADEKA (Sales ¥ 184 B)

千寿製薬 (Sales ¥ 28 B)

エスケー化研 (Sales ¥ 82 B)

TSUMURA & CO. (Sales ¥ 105 B)

持田製薬 (Sales ¥ 89 B)

Fuso Pharmaceutical Industries (Sales ¥ 48 B)

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .